HOPE Therapeutics, Inc. /
Dura Medical, LLC
HOPE Therapeutics adds Dura Medical to its clinic network




Source for the buyer and target: NRx Pharmaceuticals, Inc.
For the buyer and target.
“On September 8, 2025, NRx Pharmaceuticals (NASDAQ: NRXP, or the “Company”), principally through its subsidiary HOPE Therapeutics, Inc., a Delaware corporation, completed its previously announced acquisition of Dura Medical, LLC, a Florida limited liability company (“Dura Medical”).”
Published 12 Sep 2025
Open the sourceWhat happened
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc., completed its acquisition of Dura Medical, LLC on September 8, 2025. Dura Medical provides precision psychiatry services, including Ketamine Therapy and Transcranial Magnetic Stimulation, to Veterans and civilian patients. [01]
The source
Everything on this page comes from the source below, quoted word for word.
HOPE Therapeutics adds Dura Medical to its clinic network
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“HOPE Therapeutics adds Dura Medical to its clinic network HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc., completed its acquisition of Dura Medical, LLC on September 8, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly